cost-effective clinical intravenous software for intravenous medication

Behavior change intervention among healthcare professionals to increase adoption of cost-effective intravenous screen software to improve the safe administration of intravenous medication -A randomized controlled trial - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059846

Enrollment

Registered

2023-11-15

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A09- Infectious gastroenteritis and colitis, unspecified

Interventions

Intervention1: intravenous screen software: total study duration will be 36 weeks.intravenous screen software has been designed for use in hospital wards and for home health care. It is a device that

Eligibility

Inclusion criteria

Inclusion criteria: intravenous screen software applied to intravenous fluid which is cost-effective and monitoring should not be done frequently

Exclusion criteria

Exclusion criteria: less than 60month,more than 60 years patient of intravenous fluid

Design outcomes

Primary

Measure	Time frame
less manpower utised,costeffectiveTimepoint: 4weeks	—

Secondary

Measure	Time frame
Less economic impact & less workload on nurses will affect behavior adaptation towards Intravenous screen softwareTimepoint: 36 month	—

Countries

India

Contacts

Public Contactvarsha lamture

Datta Meghe Institute of higher education and research(DMIHER)

dryrlamture@yahoo.co.in8412045461

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026